Navigation Links
Toxic Chemicals Found in Doctors and Nurses
Date:10/8/2009

New Biomonitoring Study Detects Four Chemicals from EPA's Recently-Announced Top Priority List

WASHINGTON, Oct. 8 /PRNewswire-USNewswire/ -- Physicians for Social Responsibility (PSR), American Nurses Association (ANA) and Health Care Without Harm (HCWH) released "Hazardous Chemicals In Health Care," the first investigation of chemicals found in bodies of health care professionals.

Today's announcement was made on a national teleconference with Kristen Welker-Hood, ScD, MSN, RN, Director of Environment and Health Programs, Physicians for Social Responsibility, report co-author and principal investigator, Rebecca M. Patton, MSN, RN, CNOR, president of the American Nurses Association, Bobbi Chase-Wilding, report co-author and Organizing Director of Clean New York, and study participants.

  • 20 study participants had toxic chemicals associated with health care in their bodies
  • Each had at least 24 individual chemicals present
  • Four chemicals are on recently released EPA list of priority chemicals
  • All participants had bisphenol A, phthalates, PBDEs and PFCs, associated with chronic illness such as cancer and endocrine malfunction
  • Twelve doctors and eight nurses, two in each of 10 states - Alaska, California, Connecticut, Maine, Massachusetts, Michigan, Minnesota, New York, Oregon, and Washington - were tested

"Nurses and doctors volunteered for this study because they believe it is their responsibility to better understand how chemicals impact human health," explained Kristen Welker-Hood, ScD, MSN, RN.

This report offers preliminary indicators of what may impact the broader health care community. 62 distinct chemicals were tested: bisphenol A, mercury, perflourinated compounds, phthalates, polybrominated dipheynl ethers, and triclosan. They're used in products, from baby bottles, hand sanitizers, and medical gauges, to industrial paints, IV bags and tubes and stain-resistant clothing.

Dr. Sean Palfrey, professor of pediatrics and public health at Boston University School of Medicine, and medical director of Boston's Lead Poisoning Prevention Program says, "I was tested for chemicals that have been associated with certain diseases whose incidences are on the rise. If we as physicians are to understand our patients' health problems - from cancer to neurological harm to reproductive dysfunctions - we need to take a look at chemical exposure in our bodies."

For experts, contact info: http://www.psr.org/chemicalreport

PSR, ANA and HCWH have joined the Safer Chemicals, Healthy Families campaign to reform the Toxic Substance Control Act (TSCA). For information on Chemicals Policy www.saferchemicals.org.

SOURCE Physicians For Social Responsibility


'/>"/>
SOURCE Physicians For Social Responsibility
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. LA BioMed study finds higher survival rate among intoxicated trauma patients
2. BPA-Free Baby Bottle Manufacturer Green to Grow Urges Public to Demand Support for Californias Toxics-Free Babies and Toddlers Act (SB 797)
3. Inhibition of NF-kappa B, a key inflammatory protein, reduced radiation toxicity in zebrafish
4. Prodrug could help curb skin toxicity related to EGFR-inhibiting cancer drugs
5. Digitek Medication Recalled Due to Risk of Digitalis Toxicity
6. Cyanide Toxicity in Smoke Inhalation Victims - a Deadly but Treatable Poison
7. Toxic Chemical Threat: FDA Needs to Get BPA Out of Our Food
8. MultiVu Video Feed: SCIELE PHARMA ANNOUNCES AVAILABILITY OF ULESFIA(TM), FIRST AND ONLY FDA-APPROVED NON-NEUROTOXIC HEAD LICE TREATMENT
9. Massachusetts Warns: Bisphenol A Toxic
10. Preventing toxic shock syndrome and other severe diseases
11. California Expert Panel Concludes Bisphenol A is Not a Reproductive or Developmental Toxicant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: